Alerts will be sent to your verified email
Verify Email
SHELTER
|
Shelter Pharma
|
Deccan Health Care
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.08 % | 0.71 % | 65.41 % |
|
5yr average Equity Multiplier
|
1.38 | 1.17 | -11.28 |
|
5yr Average Asset Turnover Ratio
|
2.02 | 0.44 | 0.0 |
|
5yr Avg Net Profit Margin
|
7.29 % | 1.32 % | 0.0 |
|
Price to Book
|
0.0 | 0.46 | 2.03 |
|
P/E
|
6.77 | 42.1 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
151.86 Days | 287.43 Days | 0.0 |
|
Inventory Days
|
65.6 Days | 412.47 Days | 0.0 |
|
Days Receivable
|
77.72 Days | 66.84 Days | 0.0 |
|
Days Payable
|
5.04 Days | 105.94 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
71.95 | 10.45 | -836.53 |
|
5yr Avg ROCE
|
21.3 % | 2.21 % | 64.57 % |
|
5yr Avg Operating Profit Margin
|
11.0 % | 8.19 % | 0.0 |
|
5 yr average Debt to Equity
|
0.04 | 0.02 | -6.16 |
|
5yr CAGR Net Profit
|
138.7 % | 30.74 % | 65.28 % |
|
5yr Average Return on Assets
|
11.22 % | 0.62 % | -21.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.32 % | 18.42 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.57 % | -16.47 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shelter Pharma
|
Deccan Health Care
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|